MAPLE GROVE, Minn. – Upsher-Smith announced the launch of Dicyclomine Hydrochloride Capsules, USP 10 mg. The company now offers the product in tablet and capsule forms.
The dicyclomine hydrochloride capsule market had U.S. sales of approximately $36.8 million for the 12 months ending March 2023 according to IQVIA.
|Product||Strength||NDC #||Package Size|
|Dicyclomine HCl Capsules, USP||10 mg||0832-6053-11||100-count|
|Dicyclomine HCl Capsules, USP||10 mg||0832-6053-10||1000-count|
For questions about ordering, please call Upsher-Smith at 1-800-654-2299.
Please refer to full Prescribing Information for Dicyclomine Hydrochloride Capsules, USP here. You can also call 1-888-650-3789 to obtain a copy of the full Prescribing Information. You are encouraged to report suspected adverse reactions to Upsher-Smith Laboratories, LLC at 1-855-899-9180 or to the FDA by visitinghttp://www.fda.gov/medwatch.
Comments are closed.